CCR5 as a Natural and Modulated Target for Inhibition of HIV

Combined CXCR3/CCR5 Blockade Attenuates Acute and Chronic Rejection

(2014) G. T. Schnickel et al.   JOURNAL OF IMMUNOLOGY

Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model

(2013) P. M. Younan et al.   BLOOD

Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

(2013) T. J. Henrich et al.   JOURNAL OF INFECTIOUS DISEASES

Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient

(2013) Steven A. Yukl et al.   PLoS Pathogens

Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients with Hematologic Disorders

(2012) Mi Kwon et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hematopoietic Cell Transplantation with Cord Blood for Cure of HIV Infections

(2012) Lawrence D. Petz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Gene therapy matures in the clinic

(2012) Leonard W Seymour et al.   NATURE BIOTECHNOLOGY

CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease

(2012) F. Atzeni et al.   RHEUMATOLOGY

Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells

(2012) J. Scholler et al.   Science Translational Medicine

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions

(2011) H. Liu et al.   BLOOD

Stem cell-based anti-HIV gene therapy

(2011) Scott G. Kitchen et al.   VIROLOGY

Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2

(2010) Gero Hütter et al.   AIDS

Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation

(2010) K. Allers et al.   BLOOD

Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction

(2010) Min Liang et al.   JOURNAL OF GENE MEDICINE

Advances in the Field of Lentivector-based Transduction of T and B Lymphocytes for Gene Therapy

(2010) Cecilia Frecha et al.   MOLECULAR THERAPY

A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model

(2009) S. Shimizu et al.   BLOOD

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

(2009) Ronald T Mitsuyasu et al.   NATURE MEDICINE

Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation

(2009) Gero Hütter et al.   NEW ENGLAND JOURNAL OF MEDICINE

T lymphocyte engineeringex vivofor cancer and infectious disease

(2008) Bruce L Levine   EXPERT OPINION ON BIOLOGICAL THERAPY

Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides

(2008) R C Zahn et al.   GENE THERAPY